Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore whether BDB-001 Injection is effective and safe in
the treatment of moderate to severe hidradenitis suppurativa(HS).